Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.87) per share. This is a 42.62 percent decrease over losses of $(0.61) per share from the same period last year.
Cramer Says Microsoft ‘Simply Can’t Compete’ With Nvidia After Software Giant Launches In-House AI Chips
After Microsoft formally launched an in-house AI accelerator AI chip Maia. Cramer says the software giant can't compete with Nvidia.
